Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Weekly Irinotecan and Carboplatin in Extensive-Stage Small-Cell Lung Cancer

NCT00104793 is registered in ClinicalTrials.gov with Japan Multinational Trial Organization as lead sponsor.

NCT NCT00104793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00104793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Weekly Irinotecan and Carboplatin in Extensive-Stage Small-Cell Lung Cancer
Lead sponsor
Japan Multinational Trial Organization
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2003
Completion date
November 30, 2008
Enrollment
55 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer